PL350520A1 - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- PL350520A1 PL350520A1 PL00350520A PL35052000A PL350520A1 PL 350520 A1 PL350520 A1 PL 350520A1 PL 00350520 A PL00350520 A PL 00350520A PL 35052000 A PL35052000 A PL 35052000A PL 350520 A1 PL350520 A1 PL 350520A1
- Authority
- PL
- Poland
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO990814A NO309305B1 (en) | 1999-02-19 | 1999-02-19 | Use of benzaldehyde derivatives in the manufacture of pharmaceutical preparations for the prevention and / or treatment of cancer, as well as certain new benzaldehyde derivatives |
PCT/NO2000/000060 WO2000048610A1 (en) | 1999-02-19 | 2000-02-18 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
PL350520A1 true PL350520A1 (en) | 2002-12-16 |
Family
ID=19902986
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL00350519A PL350519A1 (en) | 1999-02-19 | 2000-02-18 | Chemical compounds |
PL00350520A PL350520A1 (en) | 1999-02-19 | 2000-02-18 | Chemical compounds |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL00350519A PL350519A1 (en) | 1999-02-19 | 2000-02-18 | Chemical compounds |
Country Status (15)
Country | Link |
---|---|
EP (2) | EP1150689A1 (en) |
JP (2) | JP2002537263A (en) |
CN (2) | CN1347322A (en) |
AU (2) | AU2834200A (en) |
BR (2) | BR0008297A (en) |
CA (2) | CA2363670A1 (en) |
CZ (2) | CZ20012966A3 (en) |
HU (2) | HUP0105280A2 (en) |
IL (2) | IL144896A0 (en) |
MX (2) | MXPA01008346A (en) |
NO (1) | NO309305B1 (en) |
PL (2) | PL350519A1 (en) |
RU (2) | RU2001123035A (en) |
SK (2) | SK11602001A3 (en) |
WO (2) | WO2000048609A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002096921A1 (en) * | 2001-05-30 | 2002-12-05 | Nisshin Seifun Group Inc. | Novel glucose derivative inducing apoptosis, process for producing the same, and use thereof as medicine |
DE10261807A1 (en) | 2002-12-19 | 2004-07-01 | Turicum Drug Development Ag | Deuterated catecholamine derivatives and medicinal products containing these compounds |
EP1910293A1 (en) * | 2005-07-26 | 2008-04-16 | Nycomed GmbH | Isotopically substituted proton pump inhibitors |
EP1912947A1 (en) * | 2005-07-26 | 2008-04-23 | Nycomed GmbH | Isotopically substituted pantoprazole |
CN101309917B (en) * | 2005-10-06 | 2013-09-11 | 奥斯拜客斯制药有限公司 | Inhibitors of the gastric h+, k+-atpase with enhanced therapeutic properties |
CN101157711B (en) * | 2007-09-28 | 2010-12-08 | 西安交通大学 | Compound having antineoplastic activity and uses thereof |
WO2009145841A1 (en) * | 2008-04-03 | 2009-12-03 | Cognate 3, Llc | Compositions and methods for immunotherapy |
CN101735284B (en) * | 2008-11-24 | 2012-05-23 | 上海医药工业研究院 | Method for preparing 4, 6-O-benzylidene-D-glucopyranose |
AU2014360452C1 (en) | 2013-12-03 | 2019-05-16 | Intra-Cellular Therapies, Inc. | Novel methods |
BR112016023162B1 (en) | 2014-04-04 | 2022-11-29 | Intra-Cellular Therapies, Inc | ORGANIC GAMMA-CARBOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS INCLUDING SAID COMPOUNDS AND USE THEREOF IN THE TREATMENT OR PROPHYLAXIS OF CENTRAL NERVOUS SYSTEM DISORDERS |
JP6898072B2 (en) * | 2015-08-27 | 2021-07-07 | 秀行 佐谷 | 14-3-3 Protein activity regulator |
EP3888656A1 (en) | 2016-03-25 | 2021-10-06 | Intra-Cellular Therapies, Inc. | Deuterated heterocyclic gamma-carboline compounds and their use in the treatment or prophylaxis of a central nervous system disorder |
CN110072518B (en) | 2016-10-12 | 2021-10-26 | 细胞内治疗公司 | Amorphous solid dispersion |
MX2019011329A (en) | 2017-03-24 | 2019-12-02 | Intra Celular Therapies Inc | Novel compositions and methods. |
MX2021002321A (en) | 2018-08-31 | 2021-04-28 | Intra Cellular Therapies Inc | Novel methods. |
AU2019328528A1 (en) | 2018-08-31 | 2021-03-18 | Intra-Cellular Therapies, Inc. | Novel methods |
KR20220029744A (en) | 2019-07-07 | 2022-03-08 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | new method |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB811510A (en) * | 1954-12-20 | 1959-04-08 | Gyogyszeripari Ki | New nitrogen-containing derivatives of polyhydroxy compounds and process for the preparation thereof |
JPS6112623A (en) * | 1984-06-28 | 1986-01-21 | Kaken Pharmaceut Co Ltd | Encephalinase inhibiting agent |
JPS6256423A (en) * | 1985-09-06 | 1987-03-12 | Kaken Pharmaceut Co Ltd | Remedy and ameliorating agent for cachexia |
GB8705780D0 (en) * | 1987-03-11 | 1987-04-15 | Norsk Hydro As | Anticancer compounds |
JPH07145191A (en) * | 1993-11-24 | 1995-06-06 | Japan Tobacco Inc | Galactosyl phosphonate derivative |
-
1999
- 1999-02-19 NO NO990814A patent/NO309305B1/en not_active IP Right Cessation
-
2000
- 2000-02-18 CA CA002363670A patent/CA2363670A1/en not_active Abandoned
- 2000-02-18 JP JP2000599400A patent/JP2002537263A/en active Pending
- 2000-02-18 WO PCT/NO2000/000059 patent/WO2000048609A1/en not_active Application Discontinuation
- 2000-02-18 JP JP2000599401A patent/JP2002537264A/en active Pending
- 2000-02-18 PL PL00350519A patent/PL350519A1/en not_active Application Discontinuation
- 2000-02-18 WO PCT/NO2000/000060 patent/WO2000048610A1/en not_active Application Discontinuation
- 2000-02-18 CZ CZ20012966A patent/CZ20012966A3/en unknown
- 2000-02-18 CZ CZ20012965A patent/CZ20012965A3/en unknown
- 2000-02-18 CN CN00806338A patent/CN1347322A/en active Pending
- 2000-02-18 MX MXPA01008346A patent/MXPA01008346A/en not_active Application Discontinuation
- 2000-02-18 IL IL14489600A patent/IL144896A0/en unknown
- 2000-02-18 HU HU0105280A patent/HUP0105280A2/en unknown
- 2000-02-18 AU AU28342/00A patent/AU2834200A/en not_active Abandoned
- 2000-02-18 RU RU2001123035/14A patent/RU2001123035A/en unknown
- 2000-02-18 SK SK1160-2001A patent/SK11602001A3/en unknown
- 2000-02-18 HU HU0105281A patent/HUP0105281A2/en unknown
- 2000-02-18 RU RU2001123124/15A patent/RU2001123124A/en unknown
- 2000-02-18 SK SK1161-2001A patent/SK11612001A3/en unknown
- 2000-02-18 PL PL00350520A patent/PL350520A1/en not_active Application Discontinuation
- 2000-02-18 CA CA002362306A patent/CA2362306A1/en not_active Abandoned
- 2000-02-18 BR BR0008297-0A patent/BR0008297A/en not_active Application Discontinuation
- 2000-02-18 CN CN00806488A patent/CN1347323A/en active Pending
- 2000-02-18 AU AU28341/00A patent/AU2834100A/en not_active Abandoned
- 2000-02-18 EP EP00906781A patent/EP1150689A1/en not_active Withdrawn
- 2000-02-18 IL IL14489500A patent/IL144895A0/en unknown
- 2000-02-18 BR BR0008302-0A patent/BR0008302A/en not_active Application Discontinuation
- 2000-02-18 EP EP00906782A patent/EP1150690A1/en not_active Withdrawn
- 2000-02-18 MX MXPA01008347A patent/MXPA01008347A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2834100A (en) | 2000-09-04 |
NO309305B1 (en) | 2001-01-15 |
CA2363670A1 (en) | 2000-08-24 |
HUP0105280A2 (en) | 2002-04-29 |
NO990814L (en) | 2000-08-21 |
MXPA01008347A (en) | 2004-03-10 |
MXPA01008346A (en) | 2003-06-06 |
JP2002537264A (en) | 2002-11-05 |
NO990814D0 (en) | 1999-02-19 |
EP1150689A1 (en) | 2001-11-07 |
PL350519A1 (en) | 2002-12-16 |
BR0008297A (en) | 2002-05-28 |
RU2001123124A (en) | 2004-02-20 |
WO2000048610A1 (en) | 2000-08-24 |
CN1347323A (en) | 2002-05-01 |
IL144896A0 (en) | 2002-06-30 |
CZ20012966A3 (en) | 2002-03-13 |
CN1347322A (en) | 2002-05-01 |
CZ20012965A3 (en) | 2002-03-13 |
WO2000048609A1 (en) | 2000-08-24 |
AU2834200A (en) | 2000-09-04 |
RU2001123035A (en) | 2004-03-20 |
SK11612001A3 (en) | 2002-04-04 |
SK11602001A3 (en) | 2002-02-05 |
IL144895A0 (en) | 2002-06-30 |
CA2362306A1 (en) | 2000-08-24 |
JP2002537263A (en) | 2002-11-05 |
BR0008302A (en) | 2002-08-27 |
EP1150690A1 (en) | 2001-11-07 |
HUP0105281A2 (en) | 2002-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9907658D0 (en) | Chemical compounds | |
GB9902461D0 (en) | Chemical compounds | |
GB9909409D0 (en) | Chemical compounds | |
PL350520A1 (en) | Chemical compounds | |
GB9903861D0 (en) | Chemical compounds | |
GB9910104D0 (en) | Chemical compounds | |
GB9910110D0 (en) | Chemical compounds | |
GB9914025D0 (en) | Chemical compounds | |
GB9900078D0 (en) | Chemical compounds | |
GB9914015D0 (en) | Chemical compounds | |
GB9910394D0 (en) | Chemical compounds | |
GB9914024D0 (en) | Chemical compounds | |
GB9910419D0 (en) | Chemical compounds | |
GB9908355D0 (en) | Chemical compounds | |
GB9914022D0 (en) | Chemical compounds | |
GB9910647D0 (en) | Chemical compounds | |
GB0001663D0 (en) | Chemical compounds | |
GB9904506D0 (en) | Chemical compounds | |
GB9905076D0 (en) | Chemical compounds | |
GB9905077D0 (en) | Chemical compounds | |
GB9905078D0 (en) | Chemical compounds | |
GB9910673D0 (en) | Chemical compounds | |
GB9910672D0 (en) | Chemical compounds | |
GB9910674D0 (en) | Chemical compounds | |
GB9910421D0 (en) | Chemical compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |